Cyclacel Pharmaceuticals, Inc. (CYCC) Social Stream



Cyclacel Pharmaceuticals, Inc. (CYCC): $0.91

0.02 (-2.15%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

D

Add CYCC to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#169 of 338

in industry

CYCLACEL PHARMACEUTICALS INC (CYCC) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering CYCLACEL PHARMACEUTICALS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-10 3 $24 $17 $21 $2.78 655.4%
2022-07-18 4 $24 $17 $20 $2.78 619.42%
2022-10-26 4 $22.001 $16 $18 $2.78 547.48%
2022-11-10 4 $22 $16 $18 $2.78 547.48%
2023-03-07 4 $22 $10 $16.25 $2.78 484.53%
2023-05-24 4 $19 $8 $13.5 $2.78 385.61%
2023-09-28 4 $16 $8 $12.25 $2.78 340.65%
2023-11-14 3 $239.88 $164.917 $204.897 $2.78 7270.4%
2023-12-19 3 $164.917 $21 $92.958 $2.78 3243.81%

The Trend in the Analyst Price Target


Over the past 29 months, CYCC's average price target has gone up $72.71.

Over the past 41 weeks, CYCC's average upside potential has been 6,907.83%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-07 4 22.000 10 16.250 0.729 2129.08%
2023-05-11 4 19.000 8 13.500 0.557 2323.7%
2023-09-28 4 16.000 8 12.250 0.344 3461.05%
2023-09-28 3 16.000 8 12.250 0.344 3461.05%
2023-12-19 3 164.917 21 92.958 3.370 2658.4%

CYCC Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.67 2 0 1 0 0 3

The Trend in the Broker Recommendations


Over the past 16 months, CYCC's average broker recommendation rating worsened by 0.67.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CYCC as an investment opportunity.

  • In terms of how CYCLACEL PHARMACEUTICALS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 1043.03% of that group.
  • CYCLACEL PHARMACEUTICALS INC's number of analysts covering the stock is greater than 122.71% of all US stocks.
  • CYCC has a higher average analyst price target than 425.46% of Healthcare stocks.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, CYCLACEL PHARMACEUTICALS INC's variance in analysts' estimates is lower than -315.7% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to CYCLACEL PHARMACEUTICALS INC are SONN, CPHI, and PRPH.

Is CYCC a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!